Multiple Sclerosis

N Engl J Med. 2018 Jan 11;378(2):169-180. doi: 10.1056/NEJMra1401483.

Authors

Daniel S Reich¹, Claudia F Lucchinetti¹, Peter A Calabresi¹

Affiliation

¹ From the Translational Neuroradiology Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda (D.S.R.), and the Departments of Neurology and Neuroscience, Johns Hopkins School of Medicine, Baltimore (P.A.C.) - both in Maryland; and the Department of Neurology, Mayo Clinic, Rochester, MN (C.F.L.).

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Review

MeSH terms

Antibodies, Monoclonal / therapeutic use
Biomarkers
Brain / pathology*
Glatiramer Acetate / therapeutic use
Humans
Immunologic Factors / therapeutic use*
Interferon-beta / therapeutic use
Magnetic Resonance Imaging
Multiple Sclerosis* / diagnostic imaging
Multiple Sclerosis* / drug therapy
Multiple Sclerosis* / etiology
Multiple Sclerosis* / pathology

Substances

Antibodies, Monoclonal
Biomarkers
Immunologic Factors
Glatiramer Acetate
Interferon-beta

Grants and funding